Grant: Collaborative Research and Development Grants
Université du Québec à Montréal
$17,391.00
Unprecedented transpositions and their applications in the synthesis of bioactive compounds
FY 2010-11
Summary
Synthesis of new bioactive compounds as new treatments for cancer, cardiovascular diseases and other nosocomial infections represents a continuing challenge for the pharmaceutical industry. Most of the compounds demonstrating useful biological properties against these diseases possess a heterocyclic or a polycyclic skeleton such as platencin, platensimycin, steroids, hamayne, rotunol and fawcettimine. Unfortunately, the natural abundance of these compounds is low and their extraction causes damage to our ecosystem. Consequently, it is extremely important to discover new synthetic methods to obtain these structures rapidly for potential biomedical application. In this context, the collaborative research project presented in this proposal in collaboration with the pharmaceutical company Boehringer Ingelheim is dedicated
to the development of novel methodologies within the concept of ""aromatic ring umpolung"". In a first part, we propose to develop unprecedented oxidative transposition processes which are extended to aromatic compounds and additionally to the concept of ""green chemistry"". The aim of these transformations is to obtain heterocyclic and polycyclic skeletons that could rapidly be used in the total synthesis of natural products. In a second part, we plan to achieve the synthesis of some of the above mentioned compounds, whose chemical structures could be quickly produced with our methodologies. Results afforded by this collaborative research project will advance organic synthesis and pharmaceutical knowledge through the discovery of different novel methodologies that are applied to the direct synthesis of highly bioactive products. Most of the structures generated could be tested for pharmaceutical development. In addition, students trained through this program
are likely to contribute in ground breaking research with concomitant health benefits and medium- to long-term impact in the Canadian industrial environment.
Program
Collaborative Research and Development Grants
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
386937-2009
Name nom
Canesi, Sylvain
Department département
Chimie
Organization id
57
Institution établissement
Université du Québec à Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2009
Award amount
17391
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3704
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Synthetic methodology
Research subject fr
Méthodologie en synthèse
Partie
1
Nb partie
3
Application title
Unprecedented transpositions and their applications in the synthesis of bioactive compounds
Keyword
NSERC
Application summary
Synthesis of new bioactive compounds as new treatments for cancer, cardiovascular diseases and other nosocomial infections represents a continuing challenge for the pharmaceutical industry. Most of the compounds demonstrating useful biological properties against these diseases possess a heterocyclic or a polycyclic skeleton such as platencin, platensimycin, steroids, hamayne, rotunol and fawcettimine. Unfortunately, the natural abundance of these compounds is low and their extraction causes damage to our ecosystem. Consequently, it is extremely important to discover new synthetic methods to obtain these structures rapidly for potential biomedical application. In this context, the collaborative research project presented in this proposal in collaboration with the pharmaceutical company Boehringer Ingelheim is dedicated
to the development of novel methodologies within the concept of ""aromatic ring umpolung"". In a first part, we propose to develop unprecedented oxidative transposition processes which are extended to aromatic compounds and additionally to the concept of ""green chemistry"". The aim of these transformations is to obtain heterocyclic and polycyclic skeletons that could rapidly be used in the total synthesis of natural products. In a second part, we plan to achieve the synthesis of some of the above mentioned compounds, whose chemical structures could be quickly produced with our methodologies. Results afforded by this collaborative research project will advance organic synthesis and pharmaceutical knowledge through the discovery of different novel methodologies that are applied to the direct synthesis of highly bioactive products. Most of the structures generated could be tested for pharmaceutical development. In addition, students trained through this program
are likely to contribute in ground breaking research with concomitant health benefits and medium- to long-term impact in the Canadian industrial environment.